Why the study?
Can a noninvasive electromagnetic expandable prosthesis be safely lengthened in a patient with an in situ ventricular assist device?
Can a noninvasive electromagnetic expandable prosthesis be safely lengthened in a patient with an in situ ventricular assist device?
This case demonstrates that noninvasive electromagnetic expandable prostheses can be safely lengthened in patients with an in situ ventricular assist device.
Supports feasibility of electromagnetic lengthening with in situ ventricular assist device; hypothesis-generating and requires prospective confirmation before practice change.
CASE: An 8-year-old girl was diagnosed with osteosarcoma of the distal femur. She underwent chemotherapy and wide resection with implantation of a noninvasive electromagnetic expandable distal femur prosthesis. Ninety-three days after chemotherapy, she developed anthracycline-induced cardiomyopathy with heart failure for which a ventricular assist device was placed. Device compatibility was tested, and she was successfully lengthened. CONCLUSION: Expandable prostheses allow limb length maintenance in skeletally immature patients who undergo limb salvage. Chemotherapy for osteosarcoma involves anthracyclines with a dose-dependent side effect of cardiotoxicity. Patients can be successfully and safely lengthened with expandable electromagnetic prostheses with in situ ventricular assist devices.
No takes yet. Share an insight, caveat, or question.
Gannon et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: